Cargando…
Development of Large-Scale Downstream Processing for Lentiviral Vectors
The interest in lentiviral vectors (LVs) has increased prominently for gene therapy applications, but few have reached the later stages of clinical trials. The main challenge has remained in scaling up the manufacturing process for the fragile vector to obtain high titers for in vivo usage. We have...
Autores principales: | Valkama, Anniina J., Oruetxebarria, Igor, Lipponen, Eevi M., Leinonen, Hanna M., Käyhty, Piia, Hynynen, Heidi, Turkki, Vesa, Malinen, Joonas, Miinalainen, Tuukka, Heikura, Tommi, Parker, Nigel R., Ylä-Herttuala, Seppo, Lesch, Hanna P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177191/ https://www.ncbi.nlm.nih.gov/pubmed/32346549 http://dx.doi.org/10.1016/j.omtm.2020.03.025 |
Ejemplares similares
-
Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells
por: Leinonen, Hanna M., et al.
Publicado: (2019) -
Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
por: Valkama, A J, et al.
Publicado: (2018) -
Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production
por: Leinonen, Hanna M., et al.
Publicado: (2020) -
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2022) -
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2023)